Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma

NCT00189722 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00189722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00189722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma
Lead sponsor
Astellas Pharma Inc
Phase
Phase 2
Overall status
Completed
Start date
Not reported
Completion date
July 31, 2005
Enrollment
160 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, bronchial, bronchial asthma